Jennifer Rosen

Summary

Country: USA

Publications

  1. pmc Barriers to intravenous penicillin use for treatment of nonmeningitis pneumococcal disease
    Jennifer Rosen
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 48:3372-4. 2010
  2. doi request reprint Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States
    Jennifer B Rosen
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 53:137-43. 2011

Detail Information

Publications2

  1. pmc Barriers to intravenous penicillin use for treatment of nonmeningitis pneumococcal disease
    Jennifer Rosen
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 48:3372-4. 2010
    ..v.) penicillin use for pneumococcal infections. The inconvenience of i.v. penicillin may limit its use despite a reduction in numbers of infections considered resistant...
  2. doi request reprint Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States
    Jennifer B Rosen
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 53:137-43. 2011
    ..Rates of invasive pneumococcal disease (IPD) varied among the United States before pneumococcal conjugate vaccine (PCV7) introduction. We compared trends in IPD rates among diverse US sites over 10 years since PCV7 introduction...